Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...

TOKYO -- Swiss pharmaceutical company Novartis has pegged its cancer-targeting radiopharmaceutical business as its next growth pillar, looking to make it "at least a $10 billion business" over the ...

TPG-backed ophthalmology specialist BVI Medical will use the investment to fund new product launches and scale its operations ...

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments ...

Dry Eye Disease Market Share and Growth dry eye disease market is estimated to be valued at USD 7.99 Bn in 2025 and is expected to reach U ...

Novartis is one of the world's top pharmaceutical ... the company's main focus – while the rest are split between Alcon, Sandoz, Vaccines and Diagnostics, Consumer Health, Shared services ...

We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against the other undervalued stocks ...

Examples include the sale of Novartis’s consumer (over-the-counter) joint venture; the divestiture of its vaccines and animal health businesses; the spinoff of Alcon, a global leader in the ...

UBS Group, Zurich Insurance Group, Holcim, Swiss Re, Alcon, Novartis and Julius Baer closed higher by 0.3 to 0.85%. Shares of dermatology company Galderma climbed about 1.7%, lifted by an ...

Novartis tumbled 5.6%. Roche Holding and Kuehne + Nagel both closed lower by about 3.5% Straumann Holding, Schindler Ps, Alcon, UBS Group, SIG Group, Lindt & Spruengli, Nestle and SGS lost 2 to 3.1%.

Alcon climbed 5.44%. Alcon's fourth-quarter ... Zurich Insurance Group and Schindler Ps posted modest gains. Novartis lost about 3.7%. The investment entity of the Sandoz family, Emasan AG ...